ArticleLeukemia research reports2025

Real-World Efficacy and Safety of Gemtuzumab Ozogamycin (GO) and 3 + 7 regimen in fit newly diagnosed Acute Myeloid Leukemia (AML) patients. A Retrospective multicenter study of "Rete Ematologica Pugliese" (REP).

M Dargenio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.